United States Women Receive More Curative Treatment for Hepatocellular Carcinoma Than Men
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Previous database studies have found gender disparities favoring men in rates of liver transplantation, which resolve in cohorts examining only patients with hepatocellular carcinoma (HCC).
Our study aims to use two large, multicenter United States (US) databases to assess for gender disparity in HCC treatment regardless of transplant listing status.
We performed a retrospective database analysis of inpatient admission data from the University Health Consortium (UHC) and the Nationwide Inpatient Sample (NIS), over a 9- and 10-year period, respectively. Adults with a primary discharge diagnosis of HCC, identified using the International Classification of Diseases 9th Edition (ICD-9) code, were included. Series of univariate and multivariate analyses were performed to examine gender disparities in metastasis, liver decompensation, treatment type, and inpatient mortality after controlling for other possible predictors.
We included 26,054 discharges from the NIS database and 25,671 patients from the UHC database in the analysis. Women with HCC appear to present less often with decompensated liver disease (OR = 0.79, p < 0.001). Furthermore they are more likely to receive invasive HCC treatment, with significantly higher rates of resection across race and diagnoses (OR = 1.34 and 1.44, p < 0.001). Univariate analyses show that US women have lower unadjusted rates of transplant; however, the disparity resolves after controlling for other clinical and demographic factors.
US women more often receive invasive treatment for HCC (especially resection) than US men with no observed disparity in transplantation rates when adjusted for pre-treatment variables.
- Ferlay, J, Shin, HR, Bray, F, Forman, D, Mathers, C, Parkin, DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: pp. 2893-2917 CrossRef
- El-Serag, HB (2011) Hepatocellular carcinoma. N Engl J Med 365: pp. 1118-1127 CrossRef
- Fattovich, G, Stroffolini, T, Zagni, I, Donato, F (2004) Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 127: pp. S35-S50 CrossRef
- Lope, CR, Tremosini, S, Forner, A, Reig, M, Bruix, J (2012) Management of HCC. J Hepatol 56: pp. S75-S87 CrossRef
- Bruix, J, Sherman, M (2005) Practice guidelines committee AeAftSoLD: Management of hepatocellular carcinoma. Hepatology 42: pp. 1208-1236 CrossRef
- Bruix, J, Sherman, M (2011) Diseases AAftSoL: Management of hepatocellular carcinoma: An update. Hepatology 53: pp. 1020-1022 CrossRef
- Forner, A, Reig, ME, Lope, CR, Bruix, J (2010) Current strategy for staging and treatment: The BCLC update and future prospects. Semin Liver Dis 30: pp. 61-74 CrossRef
- Moylan, CA, Brady, CW, Johnson, JL, Smith, AD, Tuttle-Newhall, JE, Muir, AJ (2008) Disparities in liver transplantation before and after introduction of the MELD score. JAMA 300: pp. 2371-2378 CrossRef
- University Health Consortium, (HCUP) HCaUP: National inpatient sample. http://www.uhc.edu. Accessed 5 September 2011.
- Healthcare Cost and Utilization Project (HCUP) HCaUP. National Inpatient Sample. http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 4 September 2011.
- Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: pp. 373-383 CrossRef
- Deyo, RA, Cherkin, DC, Ciol, MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: pp. 613-619 CrossRef
- Shavers, VL, Harlan, LC, Stevens, JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97: pp. 134-147 CrossRef
- Simons, JP, Ng, SC, Hill, JS, Shah, SA, Zhou, Z, Tseng, JF (2010) In-hospital mortality from liver resection for hepatocellular carcinoma: A simple risk score. Cancer 116: pp. 1733-1738 CrossRef
- Singal, AG, Chan, V, Getachew, Y, Guerrero, R, Reisch, JS, Cuthbert, JA (2012) Predictors of liver transplant eligibility for patients with hepatocellular carcinoma in a safety net hospital. Dig Dis Sci 57: pp. 580-586 CrossRef
- Dohmen, K, Shigematsu, H, Irie, K, Ishibashi, H (2003) Longer survival in female than male with hepatocellular carcinoma. J Gastroenterol Hepatol 18: pp. 267-272 CrossRef
- Kalra, M, Mayes, J, Assefa, S, Kaul, AK, Kaul, R (2008) Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World J Gastroenterol 14: pp. 5945-5961 CrossRef
- Mindikoglu, AL, Regev, A, Seliger, SL, Magder, LS (2010) Gender disparity in liver transplant waiting-list mortality: The importance of kidney function. Liver Transpl 16: pp. 1147-1157 CrossRef
- Cholongitas, E, Marelli, L, Kerry, A, Goodier, DW, Nair, D, Thomas, M, Patch, D, Burroughs, AK (2007) Female liver transplant recipients with the same GFR as male recipients have lower MELD scores—a systematic bias. Am J Transplant 7: pp. 685-692 CrossRef
- Myers, RP, Shaheen, AA, Aspinall, AI, Quinn, RR, Burak, KW (2011) Gender, renal function, and outcomes on the liver transplant waiting list: Assessment of revised MELD including estimated glomerular filtration rate. J Hepatol 54: pp. 462-470 CrossRef
- Farinati, F, Sergio, A, Giacomin, A, Nolfo, MA, Poggio, P, Benvegnu, L, Rapaccini, G, Zoli, M, Borzio, F, Giannini, EG, Caturelli, E, Trevisani, F (2009) Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?. Eur J Gastroenterol Hepatol 21: pp. 1212-1218 CrossRef
- United States Women Receive More Curative Treatment for Hepatocellular Carcinoma Than Men
Digestive Diseases and Sciences
Volume 58, Issue 10 , pp 2817-2825
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Hepatocellular carcinoma
- Industry Sectors
- Author Affiliations
- 1. Department of Medicine, Section of Gastroenterology and Hepatology, Tulane University Health Sciences Center, New Orleans, LA, USA
- 5. 5131 O Donovan Drive, 4th Floor Subspecialty Clinic, Baton Rouge, LA, 70806, USA
- 2. Department of Medicine, University of Florida, Gainesville, FL, USA
- 3. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA
- 4. Department of Medicine, George Washington University Medical Center, Washington, DC, USA